PMID- 28340165
OWN - NLM
STAT- MEDLINE
DCOM- 20190321
LR  - 20190321
IS  - 1526-4637 (Electronic)
IS  - 1526-2375 (Linking)
VI  - 19
IP  - 2
DP  - 2018 Feb 1
TI  - Attitudes Toward Opioids and Risk of Misuse/Abuse in Patients with Chronic 
      Noncancer Pain Receiving Long-term Opioid Therapy.
PG  - 319-327
LID - 10.1093/pm/pnw338 [doi]
AB  - OBJECTIVES: To determine the attitudes of patients toward long-term opioid 
      therapy (LtOT) and the potential risk of misuse/abuse in patients with chronic 
      noncancer pain (CNCP). DESIGN: Prospective, descriptive epidemiological study. 
      SETTING: Multidisciplinary tertiary care pain center within the Montreal 
      University Health Center. SUBJECTS: Patients who had had at least one visit at 
      least one year prior to the invitation. METHODS: We used four questionnaires: 
      demographic questionnaire, the Drug Attitude Inventory Modified (DAI-M), the 
      Opioid Risk Tool (ORT), and the Screening Tool for Addiction Risk (STAR). All 
      questionnaires were administered in their validated French version. RESULTS: 
      Three hundred seventy patients completed questionnaires. The response rate was 
      79.26%. Of those who responded, 61.62% women and 38.38% men, the mean age was 57 
      years. The patients had been treated with LtOT for an average of 6.31 years, and 
      the median dose per day in morphine equivalents was 48.21 mg. The DAI-M showed 
      that 32.16% had a positive attitude toward opioids, 39.73% had a negative 
      attitude, and 22.16% had a neutral attitude. The ORT questionnaire demonstrated 
      that 86.2% of the patients were at low risk of abuse/misuse, 13.2% were at 
      moderate risk, and only 0.54% were at high risk. The STAR questionnaire showed 
      that 4.2% had a low risk of abuse/misuse. CONCLUSIONS: Despite public opinion, 
      patients treated with LtOT for CNCP and followed in a tertiary care pain center 
      are at low risk for opioid misuse/abuse. We need to refine the way of prescribing 
      opioids, should be selective with our patients, and should relive their pain 
      adequately.
CI  - (c) 2017 American Academy of Pain Medicine. All rights reserved. For permissions, 
      please e-mail: journals.permissions@oup.com
FAU - Vargas-Schaffer, Grisell
AU  - Vargas-Schaffer G
AD  - Anesthesiology and Pain Management, CHUM Pain Center, Montreal, QC, Canada.
AD  - Departments of Pharmacology.
AD  - Anesthesiology, University of Montreal, Montreal, QC, Canada.
AD  - Montreal University Hospital Center, CRCHUM, Montreal, QC, Canada.
FAU - Cogan, Jennifer
AU  - Cogan J
AD  - Anesthesiology, University of Montreal, Montreal, QC, Canada.
AD  - Anesthesiology and Pain Management, Montreal Heart Institute, Montreal, QC, 
      Canada.
AD  - Montreal Heart Institute Research Center, Montreal, QC, Canada.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PL  - England
TA  - Pain Med
JT  - Pain medicine (Malden, Mass.)
JID - 100894201
RN  - 0 (Analgesics, Opioid)
SB  - IM
MH  - Adult
MH  - Aged
MH  - Analgesics, Opioid/*therapeutic use
MH  - Chronic Pain/*drug therapy
MH  - Female
MH  - *Health Knowledge, Attitudes, Practice
MH  - Humans
MH  - Male
MH  - Middle Aged
MH  - Opioid-Related Disorders/*psychology
MH  - Pain Clinics
MH  - Prospective Studies
MH  - Surveys and Questionnaires
EDAT- 2017/03/25 06:00
MHDA- 2019/03/22 06:00
CRDT- 2017/03/25 06:00
PHST- 2017/03/25 06:00 [pubmed]
PHST- 2019/03/22 06:00 [medline]
PHST- 2017/03/25 06:00 [entrez]
AID - 3062933 [pii]
AID - 10.1093/pm/pnw338 [doi]
PST - ppublish
SO  - Pain Med. 2018 Feb 1;19(2):319-327. doi: 10.1093/pm/pnw338.